167 related articles for article (PubMed ID: 19228041)
1. Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.
Dickson DP; Wardrop DJ
Org Lett; 2009 Mar; 11(6):1341-4. PubMed ID: 19228041
[TBL] [Abstract][Full Text] [Related]
2. A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.
Wehn PM; Du Bois J
Angew Chem Int Ed Engl; 2009; 48(21):3802-5. PubMed ID: 19378315
[TBL] [Abstract][Full Text] [Related]
3. New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.
Domostoj MM; Irving E; Scheinmann F; Hale KJ
Org Lett; 2004 Jul; 6(15):2615-8. PubMed ID: 15255704
[TBL] [Abstract][Full Text] [Related]
4. Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.
Hale KJ; Domostoj MM; Tocher DA; Irving E; Scheinmann F
Org Lett; 2003 Aug; 5(16):2927-30. PubMed ID: 12889910
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis of the beta-catenin inhibitor, (-)-agelastatin A: a second-generation approach based on radical aminobromination.
Yoshimitsu T; Ino T; Futamura N; Kamon T; Tanaka T
Org Lett; 2009 Aug; 11(15):3402-5. PubMed ID: 19588910
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of (-)-agelastatin A by [3.3] sigmatropic rearrangement of allyl cyanate.
Ichikawa Y; Yamaoka T; Nakano K; Kotsuki H
Org Lett; 2007 Aug; 9(16):2989-92. PubMed ID: 17602639
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.
Antropow AH; Xu K; Buchsbaum RJ; Movassaghi M
J Org Chem; 2017 Aug; 82(15):7720-7731. PubMed ID: 28696693
[TBL] [Abstract][Full Text] [Related]
8. Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation.
Mason CK; McFarlane S; Johnston PG; Crowe P; Erwin PJ; Domostoj MM; Campbell FC; Manaviazar S; Hale KJ; El-Tanani M
Mol Cancer Ther; 2008 Mar; 7(3):548-58. PubMed ID: 18347142
[TBL] [Abstract][Full Text] [Related]
9. A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.
Trost BM; Dong G
Chemistry; 2009 Jul; 15(28):6910-9. PubMed ID: 19533707
[TBL] [Abstract][Full Text] [Related]
10. Potent fluorinated agelastatin analogues for chronic lymphocytic leukemia: design, synthesis, and pharmacokinetic studies.
Stout EP; Choi MY; Castro JE; Molinski TF
J Med Chem; 2014 Jun; 57(12):5085-93. PubMed ID: 24673739
[TBL] [Abstract][Full Text] [Related]
11. Stereocontrolled synthesis of vicinal diamines by organocatalytic asymmetric Mannich reaction of N-protected aminoacetaldehydes: formal synthesis of (-)-agelastatin A.
Kano T; Sakamoto R; Akakura M; Maruoka K
J Am Chem Soc; 2012 May; 134(17):7516-20. PubMed ID: 22486203
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis of (-)-agelastatin A.
Yoshimitsu T; Ino T; Tanaka T
Org Lett; 2008 Dec; 10(23):5457-60. PubMed ID: 19006318
[TBL] [Abstract][Full Text] [Related]
13. A short total synthesis of the marine sponge pyrrole-2-aminoimidazole alkaloid (±)-agelastatin A.
Duspara PA; Batey RA
Angew Chem Int Ed Engl; 2013 Oct; 52(41):10862-6. PubMed ID: 24038621
[No Abstract] [Full Text] [Related]
14. Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.
Han S; Siegel DS; Morrison KC; Hergenrother PJ; Movassaghi M
J Org Chem; 2013 Dec; 78(23):11970-84. PubMed ID: 24152243
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric aziridination of cyclic enones using chiral diamine catalysts and its application to the total synthesis of (-)-agelastatin A.
Menjo Y; Hamajima A; Sasaki N; Hamada Y
Org Lett; 2011 Nov; 13(21):5744-7. PubMed ID: 21966984
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric synthesis of trisubstituted oxazolidinones by the thiourea-catalyzed aldol reaction of 2-isocyanatomalonate diester.
Sakamoto S; Kazumi N; Kobayashi Y; Tsukano C; Takemoto Y
Org Lett; 2014 Sep; 16(18):4758-61. PubMed ID: 25203516
[TBL] [Abstract][Full Text] [Related]
17. The
D'Ambrosio M
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836663
[TBL] [Abstract][Full Text] [Related]
18. Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.
Jouanneau M; McClary B; Reyes JC; Chen R; Chen Y; Plunkett W; Cheng X; Milinichik AZ; Albone EF; Liu JO; Romo D
Bioorg Med Chem Lett; 2016 Apr; 26(8):2092-7. PubMed ID: 26951751
[TBL] [Abstract][Full Text] [Related]
19. Alkynyliodonium salts in organic synthesis. Development of a unified strategy for the syntheses of (-)-agelastatin A and (-)-agelastatin B.
Feldman KS; Saunders JC; Wrobleski ML
J Org Chem; 2002 Oct; 67(20):7096-109. PubMed ID: 12354005
[TBL] [Abstract][Full Text] [Related]
20. Compounds, compositions, and methods of agelastatin alkaloids: patent evaluation of WO2015042239 (A1).
Yoshimitsu T; Tun HW
Expert Opin Ther Pat; 2017 Feb; 27(2):113-119. PubMed ID: 28056571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
